查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球原位雜合技術市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測
市場調查報告書
商品編碼
1305159

全球原位雜合技術市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global In Situ Hybridization Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 350 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2030年，全球原位雜合技術市場需求將從2022年的29億美元達到82.4億美元，2023-2030年復合年成長率為13.95%。

原位雜合技術或ISH是分子生物學和遺傳學中用於檢測和定位細胞或組織中特定DNA或RNA序列的技術。它包括使用與目標序列互補的標記探針與被研究樣本中的核酸結合併雜交。 ISH可用於鑑定細胞或組織中特定基因序列的存在與否，以及確定這些序列在細胞或組織中的位置。該技術廣泛用於研究基因表達、染色體異常和病毒感染。

市場動態：

個性化醫療的發展取決於準確識別和診斷基因突變和改變的能力。 ISH是這一過程的關鍵工具，它使研究人員和臨床醫生能夠檢測細胞或組織中的特定核酸序列，從而為治療決策提供資訊並改善患者預後。隨著測序技術的進步和基因數據可用性的不斷提高，基因組學領域正在迅速擴大。 ISH是研究基因表達和特定基因在基因組中位置的關鍵工具，使其成為基因組學研究的重要技術。癌症和神經系統疾病等疾病的發病率在全球範圍內不斷上升。 ISH是診斷和治療慢性疾病的重要工具，使臨床醫生能夠準確識別導致疾病發生和發展的基因突變和改變。用於ISH的新探針和檢測方法的開發推動了該領域的創新，使研究人員和臨床醫生能夠以更高的準確性和靈敏度檢測更少量的核酸。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於在全球範圍內清晰地了解行業結構並評估競爭吸引力。此外，這些工具還對全球原位雜合技術市場的各個細分市場進行了全面評估。原位雜合技術行業的成長和趨勢為本研究提供了整體方法。

市場細分：

原位雜合技術市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按技術分類

  • 螢光原位雜合技術（FISH）
  • 原位變色雜交（CISH）

按探針

  • DNA探針
  • RNA

按產品

  • 儀器
  • 試劑盒和探針
  • 軟體
  • 服務

按應用

  • 癌症
  • 細胞遺傳學
  • 發育生物學
  • 傳染病
  • 其他

按終端用戶分類

  • 研究和診斷實驗室
  • CRO
  • 學術機構
  • 其他

區域分析

本部分涵蓋了區域前景，突出了北美、歐洲、亞太、拉丁美洲以及中東和非洲地區對原位雜合技術市場的當前和未來需求。此外，報告還重點分析了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。原位雜合技術市場的主要參與者包括Thermo Fisher Scientific Inc.、Abbott (Abbott Molecular)、PerkinElmer Inc.、BioView、Agilent Technologies Inc.、Merck KGaA、Bio-Rad Laboratories Inc.、Oxford Gene Technology IP Limited、Leica Biosystems Nussloch GmbH、F. Hoffman-La Roche Limited、NeoGenomics Laboratories Inc.和Advanced Cell Diagnostics Inc.。本節包括競爭格局的整體觀點，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

目 錄

第一章：前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章：執行摘要

  • 市場亮點
  • 全球市場概況

第三章：原位雜合技術-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 按探頭市場吸引力分析
    • 按產品市場吸引力分析
    • 市場吸引力分析：按應用
    • 市場吸引力分析：按最終用途
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

5.COVID-19疫情影響分析

第六章：全球原位雜合技術市場分析：按技術分類

  • 技術概述
  • 歷史和預測數據
  • 按技術分析
  • 螢光原位雜合技術（FISH）
  • 顯色原位雜合技術（CISH）

第七章：全球原位雜合技術市場分析：按探針分類

  • 探針概述
  • 歷史和預測數據
  • 按探針分析
  • DNA探針
  • RNA

第八章：全球原位雜合技術市場分析：按產品分類

  • 產品概述
  • 歷史和預測數據
  • 按產品分析
  • 儀器
  • 試劑盒和探針
  • 軟體
  • 服務

第九章：全球原位雜合技術市場分析：按應用分類

  • 概述：按應用分類
  • 歷史和預測數據
  • 分析：按應用
  • 癌症
  • 細胞遺傳學
  • 發育生物學
  • 傳染病
  • 其他

第10章：全球原位雜合技術市場分析：按最終用途分類

  • 終端用途概述
  • 歷史和預測數據
  • 按最終用途分析
  • 研究與診斷實驗室
  • CRO
  • 學術機構
  • 其他

第十一章：全球原位雜合技術市場分析：按地域分類

  • 頂級公司佔有率分析
  • 公司介紹
  • 北美銷售分析
    • 概述，歷史和預測銷售分析
    • 北美細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區各細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲各細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第十二章：原位雜合技術企業競爭格局

  • 原位雜合技術市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第十三章：公司概況

  • 公司佔有率分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Abbott (Abbott Molecular)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • PerkinElmer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • BioView
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Agilent Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Bio-Rad Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Oxford Gene Technology IP Limited
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Leica Biosystems Nussloch GmbH
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • F. Hoffman-La Roche Limited
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • NeoGenomics Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Advanced Cell Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

*注：在公司概況中，財務細節和近期發展取決於可用性，如果是私營公司，則可能不包括在內。

Product Code: VMR112110579

The global demand for In Situ Hybridization Market is presumed to reach the market size of nearly USD 8.24 BN by 2030 from USD 2.9 BN in 2022 with a CAGR of 13.95% under the study period 2023 - 2030.

In Situ Hybridization or ISH is a technique used in molecular biology and genetics to detect and localize specific DNA or RNA sequences in cells or tissues. It involves using labelled probes, which are complementary to the target sequence of interest, to bind and hybridize with the nucleic acids in the sample being studied. ISH can be used to identify the presence or absence of specific genetic sequences in cells or tissues, as well as to determine the location of those sequences within the cell or tissue. This technique is widely used in research to study gene expression, chromosomal abnormalities, and viral infections. 

Market Dynamics:

The development of personalized medicine is dependent on the ability to accurately identify and diagnose genetic mutations and alterations. ISH is a critical tool for this process, enabling researchers and clinicians to detect specific nucleic acid sequences in cells or tissues, which can inform treatment decisions and improve patient outcomes. The field of genomics is rapidly expanding, driven by advances in sequencing technologies and the growing availability of genetic data. ISH is a key tool for studying gene expression and the location of specific genes within the genome, making it an essential technique for genomics research. The prevalence of diseases, such as cancer and neurological disorders, is increasing globally. ISH is a critical tool for diagnosing and treating chronic diseases, enabling clinicians to accurately identify genetic mutations and alterations that contribute to disease development and progression. The development of new probes and detection methods for ISH is driving innovation in the field, enabling researchers and clinicians to detect smaller quantities of nucleic acids with higher accuracy and sensitivity. 

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in situ hybridization. The growth and trends of in situ hybridization industry provide a holistic approach to this study. 

Market Segmentation:

This section of the in situ hybridization market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Technology

  • Fluorescent In Situ Hybridization (FISH)
  • Chromogenic In Situ Hybridization (CISH)

By Probe

  • DNA
  • RNA

By Product

  • Instruments
  • Kits & Probes
  • Software
  • Services

By Application

  • Cancer
  • Cytogenetics
  • Developmental Biology
  • Infectious Diseases
  • Others

By End-Use

  • Research & Diagnostic Laboratories
  • CROs
  • Academic Institutes
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the In Situ Hybridization market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in situ hybridization market include Thermo Fisher Scientific Inc., Abbott (Abbott Molecular), PerkinElmer Inc., BioView, Agilent Technologies Inc., Merck KGaA, Bio-Rad Laboratories Inc., Oxford Gene Technology IP Limited, Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories Inc., Advanced Cell Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IN SITU HYBRIDIZATION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Probe
    • 3.7.3 Market Attractiveness Analysis By Product
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5.  IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Fluorescent In Situ Hybridization (FISH) Historic and Forecast Sales by Regions
  • 6.5 Chromogenic In Situ Hybridization (CISH) Historic and Forecast Sales by Regions

7 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY PROBE

  • 7.1 Overview by Probe
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Probe
  • 7.4 DNA Historic and Forecast Sales by Regions
  • 7.5 RNA Historic and Forecast Sales by Regions

8 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY PRODUCT

  • 8.1 Overview by Product
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Product
  • 8.4 Instruments Historic and Forecast Sales by Regions
  • 8.5 Kits & Probes Historic and Forecast Sales by Regions
  • 8.6 Software Historic and Forecast Sales by Regions
  • 8.7 Services Historic and Forecast Sales by Regions

9 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Cancer Historic and Forecast Sales by Regions
  • 9.5 Cytogenetics Historic and Forecast Sales by Regions
  • 9.6 Developmental Biology Historic and Forecast Sales by Regions
  • 9.7 Infectious Diseases Historic and Forecast Sales by Regions
  • 9.8 Others Historic and Forecast Sales by Regions

10 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY END-USE

  • 10.1 Overview by End-use
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-use
  • 10.4 Research & Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.5 CROs Historic and Forecast Sales by Regions
  • 10.6 Academic Institutes Historic and Forecast Sales by Regions
  • 10.7 Others Historic and Forecast Sales by Regions

11 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top  Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE IN SITU HYBRIDIZATION COMPANIES

  • 12.1. In Situ Hybridization Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF IN SITU HYBRIDIZATION INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Abbott (Abbott Molecular)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. PerkinElmer Inc.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. BioView
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Agilent Technologies Inc.
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Merck KGaA
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Bio-Rad Laboratories Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Oxford Gene Technology IP Limited
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Leica Biosystems Nussloch GmbH
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. F. Hoffman-La Roche Limited
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. NeoGenomics Laboratories Inc.
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Advanced Cell Diagnostics Inc.
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Analysis by Technology (USD MN)
  •  Fluorescent In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Chromogenic In Situ Hybridization (CISH) Market Sales by Geography (USD MN)
  •  Analysis Market by Probe (USD MN)
  •  DNA Market Sales by Geography (USD MN)
  •  RNA Market Sales by Geography (USD MN)
  •  Analysis by Product (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Kits & Probes Market Sales by Geography (USD MN)
  •  Software Market Sales by Geography (USD MN)
  •  Services Market Sales by Geography (USD MN)
  •  Analysis by Application (USD MN)
  •  Cancer Market Sales by Geography (USD MN)
  •  Cytogenetics Market Sales by Geography (USD MN)
  •  Developmental Biology Market Sales by Geography (USD MN)
  •  Infectious Diseases Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by End-use (USD MN)
  •  Research & Diagnostic Laboratories Market Sales by Geography (USD MN)
  •  CROs Market Sales by Geography (USD MN)
  •  Academic Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global In Situ Hybridization Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition

LIST OF FIGURES

  •  Research Scope of In Situ Hybridization Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global In Situ Hybridization Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Technology
  •  Market Attractiveness Analysis by Probe
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by End-use
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Technology (USD MN)
  •  Fluorescent In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Chromogenic In Situ Hybridization (CISH) Market Sales by Geography (USD MN)
  •  Global Market Analysis by Probe (USD MN)
  •  DNA Market Sales by Geography (USD MN)
  •  RNA Market Sales by Geography (USD MN)
  •  Global Market Analysis by Product (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Kits & Probes Market Sales by Geography (USD MN)
  •  Software Market Sales by Geography (USD MN)
  •  Services Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  Cancer Market Sales by Geography (USD MN)
  •  Cytogenetics Market Sales by Geography (USD MN)
  •  Developmental Biology Market Sales by Geography (USD MN)
  •  Infectious Diseases Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by End-use (USD MN)
  •  Research & Diagnostic Laboratories Market Sales by Geography (USD MN)
  •  CROs Market Sales by Geography (USD MN)
  •  Academic Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top  Company Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.